Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial
暂无分享,去创建一个
N. Taira | H. Iwata | H. Mukai | T. Kawahara | Y. Uemura | S. Baba | Y. Hagiwara | T. Shiroiwa | K. Shimozuma | M. Sawaki | K. Kobayashi | Y. Takumoto | M. Takahashi | Takuya Kawahara